TNF and dengue disease: While immunomodulators (such as IL-6 inhibitors or tumor necrosis factor alpha (TNF-alpha) blockers) show promise in other inflammatory conditions, their use in severe dengue remains investigational, with limited preliminary data and concern about potential hemorrhagic complications.